James Christensen
2017
In 2017, James Christensen earned a total compensation of $690.9K as Senior Vice President and Chief Scientific Officer at Mirati Therapeutics, a 60% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $115,400 |
|---|---|
| Option Awards | $211,900 |
| Salary | $360,700 |
| Other | $2,920 |
| Total | $690,920 |
Christensen received $360.7K in salary, accounting for 52% of the total pay in 2017.
Christensen also received $115.4K in non-equity incentive plan, $211.9K in option awards and $2.9K in other compensation.
Rankings
In 2017, James Christensen's compensation ranked 10,672nd out of 14,666 executives tracked by ExecPay. In other words, Christensen earned more than 27.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,672 out of 14,666 | 27th |
Division Manufacturing | 4,163 out of 5,772 | 28th |
Major group Chemicals And Allied Products | 1,486 out of 2,075 | 28th |
Industry group Drugs | 1,214 out of 1,731 | 30th |
Industry Pharmaceutical Preparations | 945 out of 1,333 | 29th |
Source: SEC filing on April 20, 2018.
Christensen's colleagues
We found four more compensation records of executives who worked with James Christensen at Mirati Therapeutics in 2017.
2017
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2017
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2017
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
2017
Chris LeMasters
Mirati Therapeutics